Literature DB >> 32266088

Vaginal microbiomes and ovarian cancer: a review.

Jinyun Xu1,2, Jing-Jie Peng3, Wenqing Yang1,2, Kun Fu1,2, Yu Zhang1,2.   

Abstract

The human microbiome, often termed as "the forgotten organ", is an aggregation of microorganisms and their genomes that forms a mutualistic complex with the host. Recent research has shown the symbiotic merits of a microbiome ecosystem and its crucial role in the hosts' physiological functions. Disruption of this symbiotic relationship is prone to cause a broad spectrum of ailments, including cancer. The compositional and environmental factors that tip the scales from beneficial co-existence to the development of malignancy is actively investigated. Herein we review the latest research in knowledge regarding the association between the vaginal microbiomes and oncogenesis, with a particular focus on ovarian carcinoma. AJCR
Copyright © 2020.

Entities:  

Keywords:  HPV; Vaginal microbiome; cervical cancer; immune response; ovarian cancer

Year:  2020        PMID: 32266088      PMCID: PMC7136922     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  91 in total

1.  Possible Epithelial Ovarian Cancer Association with HPV18 or HPV33 Infection.

Authors:  Pei-Pei Zhang; Lei Zhou; Jia-Shi Cao; Yi-Ping Li; Zhi Zeng; Ni Sun; Li Shen; Hao-Yue Zhu; Yang Ruan; Wen-Ting Zha; Xin-Yu Wang; Ke-Qiang Zhang; Ran Zhang
Journal:  Asian Pac J Cancer Prev       Date:  2016

Review 2.  Sexually transmitted infections: challenges ahead.

Authors:  Magnus Unemo; Catriona S Bradshaw; Jane S Hocking; Henry J C de Vries; Suzanna C Francis; David Mabey; Jeanne M Marrazzo; Gerard J B Sonder; Jane R Schwebke; Elske Hoornenborg; Rosanna W Peeling; Susan S Philip; Nicola Low; Christopher K Fairley
Journal:  Lancet Infect Dis       Date:  2017-07-09       Impact factor: 25.071

3.  Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment.

Authors:  Noriho Iida; Amiran Dzutsev; C Andrew Stewart; Loretta Smith; Nicolas Bouladoux; Rebecca A Weingarten; Daniel A Molina; Rosalba Salcedo; Timothy Back; Sarah Cramer; Ren-Ming Dai; Hiu Kiu; Marco Cardone; Shruti Naik; Anil K Patri; Ena Wang; Francesco M Marincola; Karen M Frank; Yasmine Belkaid; Giorgio Trinchieri; Romina S Goldszmid
Journal:  Science       Date:  2013-11-22       Impact factor: 47.728

4.  Inhibitory Effect of Vaginal Lactobacillus Supernatants on Cervical Cancer Cells.

Authors:  Ke-Di Wang; Dong-Jiang Xu; Bao-Ya Wang; Dong-Hui Yan; Zhi Lv; Jian-Rong Su
Journal:  Probiotics Antimicrob Proteins       Date:  2018-06       Impact factor: 4.609

5.  Interplay between the temporal dynamics of the vaginal microbiota and human papillomavirus detection.

Authors:  Rebecca M Brotman; Michelle D Shardell; Pawel Gajer; J Kathleen Tracy; Jonathan M Zenilman; Jacques Ravel; Patti E Gravitt
Journal:  J Infect Dis       Date:  2014-06-18       Impact factor: 5.226

6.  Nucleoside-catabolizing enzymes in mycoplasma-infected tumor cell cultures compromise the cytostatic activity of the anticancer drug gemcitabine.

Authors:  Johan Vande Voorde; Suna Sabuncuoğlu; Sam Noppen; Anders Hofer; Farahnaz Ranjbarian; Steffen Fieuws; Jan Balzarini; Sandra Liekens
Journal:  J Biol Chem       Date:  2014-03-25       Impact factor: 5.157

7.  Prevalent high-risk HPV infection and vaginal microbiota in Nigerian women.

Authors:  E O Dareng; B Ma; A O Famooto; S N Adebamowo; R A Offiong; O Olaniyan; P S Dakum; C M Wheeler; D Fadrosh; H Yang; P Gajer; R M Brotman; J Ravel; C A Adebamowo
Journal:  Epidemiol Infect       Date:  2015-06-11       Impact factor: 4.434

8.  Association of the vaginal microbiota with human papillomavirus infection in a Korean twin cohort.

Authors:  Jung Eun Lee; Sunghee Lee; Heetae Lee; Yun-Mi Song; Kayoung Lee; Min Ji Han; Joohon Sung; GwangPyo Ko
Journal:  PLoS One       Date:  2013-05-22       Impact factor: 3.240

9.  Association of Chlamydia trachomatis infection with human papillomavirus (HPV) & cervical intraepithelial neoplasia - a pilot study.

Authors:  Neerja Bhatla; Kriti Puri; Elizabeth Joseph; Alka Kriplani; Venkateswaran K Iyer; V Sreenivas
Journal:  Indian J Med Res       Date:  2013-03       Impact factor: 2.375

10.  Lack of Significant Effects of Chlamydia trachomatis Infection on Cervical Adenocarcinoma Risk: Nested Case-Control Study.

Authors:  Vitaly Smelov; Tarik Gheit; Karin Sundström; Alexander Ploner; Sandrine McKay-Chopin; Carina Eklund; Massimo Tommasino; Joakim Dillner
Journal:  PLoS One       Date:  2016-05-26       Impact factor: 3.240

View more
  7 in total

1.  Metagenomic analysis of the microbiome of the upper reproductive tract: combating ovarian cancer through predictive, preventive, and personalized medicine.

Authors:  Xu Qin; Jianglin Zhou; Zizhuo Wang; Chenzhao Feng; Junpeng Fan; Jia Huang; Dianxing Hu; Babak Baban; Shengqi Wang; Ding Ma; Chaoyang Sun; Zhe Zhou; Gang Chen
Journal:  EPMA J       Date:  2022-06-23       Impact factor: 8.836

Review 2.  Novel directions of precision oncology: circulating microbial DNA emerging in cancer-microbiome areas.

Authors:  Liting You; Juan Zhou; Zhaodan Xin; J Spencer Hauck; Feifei Na; Jie Tang; Xiaohan Zhou; Zichen Lei; Binwu Ying
Journal:  Precis Clin Med       Date:  2022-02-03

Review 3.  Host microbiota can facilitate pathogen infection.

Authors:  Emily J Stevens; Kieran A Bates; Kayla C King
Journal:  PLoS Pathog       Date:  2021-05-13       Impact factor: 6.823

Review 4.  The role of the microbiome in ovarian cancer: mechanistic insights into oncobiosis and to bacterial metabolite signaling.

Authors:  Adrienn Sipos; Gyula Ujlaki; Edit Mikó; Eszter Maka; Judit Szabó; Karen Uray; Zoárd Krasznai; Péter Bai
Journal:  Mol Med       Date:  2021-04-01       Impact factor: 6.354

Review 5.  A Comprehensive Review of the Current and Future Role of the Microbiome in Pancreatic Ductal Adenocarcinoma.

Authors:  Nabeel Merali; Tarak Chouari; Kayani Kayani; Charles J Rayner; José I Jiménez; Jonathan Krell; Elisa Giovannetti; Izhar Bagwan; Kate Relph; Timothy A Rockall; Tony Dhillon; Hardev Pandha; Nicola E Annels; Adam E Frampton
Journal:  Cancers (Basel)       Date:  2022-02-17       Impact factor: 6.639

6.  Shifts in gut and vaginal microbiomes are associated with cancer recurrence time in women with ovarian cancer.

Authors:  David Jacobson; Kathleen Moore; Camille Gunderson; Michelle Rowland; Rita Austin; Tanvi Prasad Honap; Jiawu Xu; Christina Warinner; Krithivasan Sankaranarayanan; Cecil M Lewis
Journal:  PeerJ       Date:  2021-06-17       Impact factor: 2.984

Review 7.  A Review of the Clinical Characteristics and Novel Molecular Subtypes of Endometrioid Ovarian Cancer.

Authors:  Shuangfeng Chen; Yuebo Li; Lili Qian; Sisi Deng; Luwen Liu; Weihua Xiao; Ying Zhou
Journal:  Front Oncol       Date:  2021-06-03       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.